Intravitreal anti-VEGF monotherapy vs intravitreal anti-VEGF combined with low dose triamcinolone (2 mg) in central retinal vein occlusion

Joel Mudri, Jane Khan, Chandrashan Perera

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	142-142
Number of pages	1
Journal	Clinical and Experimental Ophthalmology
Volume	47
Publication status	Published - Nov 2019

Cite this

@article{6499c085961941a2a3c19e800ff4da1d,

title = "Intravitreal anti-VEGF monotherapy vs intravitreal anti-VEGF combined with low dose triamcinolone (2 mg) in central retinal vein occlusion",

author = "Joel Mudri and Jane Khan and Chandrashan Perera",

year = "2019",

month = nov,

language = "English",

volume = "47",

pages = "142--142",

journal = "Clinical and Experimental Ophthalmology",

issn = "1442-6404",

publisher = "John Wiley & Sons",

}

TY - JOUR

T1 - Intravitreal anti-VEGF monotherapy vs intravitreal anti-VEGF combined with low dose triamcinolone (2 mg) in central retinal vein occlusion

AU - Mudri, Joel

AU - Khan, Jane

AU - Perera, Chandrashan

PY - 2019/11

Y1 - 2019/11

M3 - Abstract/Meeting Abstract

SN - 1442-6404

VL - 47

SP - 142

EP - 142

JO - Clinical and Experimental Ophthalmology

JF - Clinical and Experimental Ophthalmology

ER -